This inventor holds 7 USPTO granted patents and 2 published patent applications. Top assignees: Genencor International, Inc., Danisco US Inc.. Active years: 2003-2013.
Company Filing History:
Years Active: 2003-2013
Title: The Innovative Contributions of Jonathan Trent
Introduction
Jonathan Trent is a notable inventor based in La Silva Beach, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel catalysts for industrial processes. With a total of 7 patents to his name, Trent's work has had a considerable impact on various applications.
Latest Patents
Among his latest patents are "2,5-diketo-L-gluconic acid reductases and methods of use." This patent describes novel nucleic acids, proteins, and methods that can be utilized to create new catalysts with desirable traits for industrial processes. In particular, it highlights novel reductases isolated from the environment using PCR methods. Another significant patent is focused on "Methods for converting glucose to ascorbic acid," which also details novel nucleic acids, proteins, and methods for developing new catalysts.
Career Highlights
Throughout his career, Jonathan Trent has worked with prominent companies such as Genencor International, Inc. and Danisco US Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in biotechnology.
Collaborations
Trent has collaborated with notable individuals in his field, including Mark Donnelly and William H. Eschenfeldt. These partnerships have further enhanced his research and development efforts.
Conclusion
Jonathan Trent's innovative work and numerous patents underscore his significant role in advancing biotechnology. His contributions continue to influence industrial processes and catalysis, showcasing the importance of his research in the field.
